ClinicalTrials.gg
Enrolling by invitationNCT06937606GLOWUpdated Apr 22, 2025

Decrease Caregiving Fatigue in Group Leaders of a Support Group for Women After Cancer

An interventional study of Self-compassion training in Caregiver Burden, sponsored by Wuerzburg University Hospital. Enrolling by invitation at 1 site in Germany. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-22.

Sponsored by Wuerzburg University Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Caregiver Burden with a site in Germany — 5 open to participants now, 5 under way, none of them phase 3. Caregiver Burden · Germany.

Started
2024
the only one that year
No phase
3 of 11
2 open now
Registered
9th of 11
by date
Lead sponsor
1 of 11
Wuerzburg University Hospital

Among the 11 studies in Caregiver Burden with a site in Germany, this one is the only one that started in 2024, is one of 3 with no phase, and was the 9th registered.

Caregiver Burden

503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

5 of the 11 studies in Caregiver Burden with a site in Germany are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Caregiver Burden with a site in Germany, or all of them as a file.
02

Study summary

This exploratory study aims to evaluate the effect of a self-compassion training developed for health professionals on leaders of self-help groups.

Hypothesis/primary goal: An online group intervention adapted from the "Self-compassion for health-care communities program" validated for health professionals leads to an increase in self-compassion among leaders of cancer self-help groups. Secondary goals: level of self-compassion at the end of the course as a mediator for therapeutic variables after 6 weeks, decrease in caregiver fatigue, secondary traumatic stress/burnout risk, personal distress and sick leave, decrease in fears of self-compassion/compassion for others; increase in mindfulness, self-efficacy, compassion for others and resilience; direct costs; safety;

Intervention:

Online group intervention: led by a certified mindfulness teacher for Mindful Self-Compassion and additional qualification in Self-Compassion in Healthcare Communities (duration: 6 weekly appointments of 90 min each); control intervention: waiting group

03

Conditions studied

  • Caregiver Burden

Keywords

  • self-compassion training
  • cancer care
  • empathy fatigue
  • burnout
  • resilience
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Group leaders of a self-help group for cancer patients
  • written

Exclusion criteria

Exclusion Criteria:

  • Medical or mental condition that, in the opinion of the investigator, does not allow the participant to take part in the study or to provide a legally valid signature of the (e.g. insufficiently controlled pre-existing mental illness or post-traumatic stress disorder)
  • Lack of willingness to store and share personal health data as part of the protocol
  • Participation in another mindfulness study
  • Lack of knowledge of German
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Self-compassion training

    Online group intervention: led by a certified mindfulness teacher for mindful self-compassion and additional qualification in self-compassion in healthcare communities (duration: 6 weekly appointments of 90 min each);

    Behavioral: Self-compassion training

  • No intervention
    waiting list control

    waiting list control

Interventions

  • BehavioralSelf-compassion training

    Online group intervention: led by a certified mindfulness teacher for mindful self-compassion and additional qualification in self-compassion in healthcare communities (duration: 6 weekly appointments of 90 min each);

06

What researchers measure

Primary outcomes

  1. self-compassion as assessed by Self-compassion scale in german version (SCS-D)

    Determining self-compassion after the intervention by means of a confirmatory test for group differences in the primary endpoint according to the ITT principle using a linear regression model; instrument: SCS-D

    Time frame: 6 weeks after baseline

Secondary outcomes

  1. Decrease in compassion fatigue as assessed by ProQoL

    Professional Quality of Life (ProQOL) is intended for any helper - health care professionals, social service workers, teachers, attorneys, emergency response, etc. Understanding the positive and negative aspects of helping those who experience trauma and suffering can improve your ability to help them and your ability to keep your own balance.

    Time frame: 12 weeks after baseline

  2. secondary traumatic stress/burnout risk as assesd by ProQoL

    Professional Quality of Life (ProQOL) is intended for any helper - health care professionals, social service workers, teachers, attorneys, emergency response, etc. Understanding the positive and negative aspects of helping those who experience trauma and suffering can improve your ability to help them and your ability to keep your own balance.

    Time frame: 12 weeks after baseline

  3. personal distress (PSS-10)

    The Perceived Stress Scale (PSS-10) is a 10-item questionnaire originally developed by Cohen et al. (1983) widely used to assess stress levels in young people and adults aged 12 and above. It evaluates the degree to which an individual has perceived life as unpredictable, uncontrollable and overloading over the previous month.

    Time frame: 12 weeks after baseline

  4. decrease in fears of self-compassion (FCS)

    The FCS-A assesses fear of compassion for self, fear of compassion for others, and fear of compassion from others and. It identifies barriers to giving compassion to oneself (15 items), to others (10 items), and receiving compassion from others (13 items). The items are rated on a five-point Likert scale (0 = Don't agree at all, 4 = Completely agree). The higher the score, the greater the one's fears, blocks and resistances to compassion.

    Time frame: 12 weeks after baseline

  5. compassion for others (COS-7)

    The questionnaire uses a 7 point Likert scale ranging from 1 (not at all true of me) to 7 (very true of me) to capture levels of compassion. Total scores are derived by averaging all item scores. Higher total scores indicate higher levels of compassion for others (strangers). https://doi.org/10.1007/s12144-020-01344-5

    Time frame: 12 weeks after baseline

  6. increase in mindfulness (FFMQ)

    The Five Facet Mindfulness Questionnaire (FFMQ-15) is a 15 question self-report scale that measures mindfulness with regards to thoughts, experiences, and actions in daily life (Baer, Carmody, \& Hunsinger, 2012).

    Time frame: 12 weeks after baseline

  7. increase in self-efficacy (SWE)

    The scales can be used to measure beliefs about subjective controllability and competence expectations in various demanding situations, namely at school, in higher education, and in everyday life. The method is primarily intended for use in scientific research. Jerusalem, M. \& Schwarzer, R. (1981). "Selbstwirksamkeit". WIRK. In R. Schwarzer (Hrsg.) (1986), Skalen zur Befindlichkeit und Persönlichkeit (Forschungsbericht 5. S. 15-28). Berlin: Freie Universität, Institut für Psychologie.

    Time frame: 12 weeks after baseline

  8. increase in resilience (BRS)

    The BRS is a reliable means of assessing resilience as the ability to bounce back or recover from stress and may provide unique and important information. The BRS consists of six items. Items 1, 3, and 5 are phrased positively, while items 2, 4, and 6 are phrased negatively. The BRS is evaluated by recoding items 2, 4, and 6 and calculating the mean value of the six items.

    Time frame: 12 weeks after baseline

  9. Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

    Time frame: 12 weeks after baseline

07

Study locations

1 site
  • Comprehensive Cancer Center Würzburg
    Wuerzburg, Bavaria 97080, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Jun 2025, 10 months after the start.

Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 10 months is below that.

Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2024
First posted
Apr 22, 2025
StartActual
Jul 31, 2024
Primary completionEst.
Jun 16, 2025
CompletionEst.
May 1, 2026
Last update
Apr 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06937606
Lead sponsor
Wuerzburg University Hospital
Collaborators
Robert Bosch Medical Center, University Hospital Tuebingen
Responsible party
Dr. Claudia Loeffler (PD Dr. med., Senior physician, Wuerzburg University Hospital) — Principal investigator
First posted
Apr 22, 2025
Start date
Jul 31, 2024
Primary completion
Jun 16, 2025 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Apr 22, 2025

Study contacts

Claudia Löffler, PD Dr. med.
principal investigator · Medizinische klinik und Poliklinik II

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion